Back to Top
Vedolizumab Biosimilar - Research Grade
Add recommended extras
Bulk Vedolizumab Biosimilar - Research Grade
| Product Specific Citations |
Dipasquale et al. Biosimilars in Pediatric IBD: Updated Considerations for Disease Management |
|---|---|
| Concentration | 1.0 - 5.0 mg/ml |
| Isotype | Human IgG1 |
| Host | Humanized |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human Integrin alpha 4 + beta 7. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Vedolizumab. |
| Species Reactivity | Human |
| Target | Integrin alpha 4 + beta 7 |
| Shipping Conditions | Blue ice |
| background | Vedolizumab, an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells that binds to the human _4_7 integrin. Vedolizumab has an approximate molecular weight of 147 kilodaltons. |
| Other names | ITGA4, ITGB7 |
| UniProt | P13612 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |
Product Benefits:
ichorbio's Vedolizumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility. ichorbio: the best antibodies for in vivo research.
Size:
ichorbio's research grade vedolizumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our vedolizumab biosimilar - please contact us for pricing.
Isotype Control:
Write Your Own Review
Who Viewed This Also Viewed
